These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7554525

  • 1. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
    Kronenberg F, König P, Lhotta K, Steinmetz A, Dieplinger H.
    Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
    [Abstract] [Full Text] [Related]

  • 2. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J, Scherberich JE.
    MMW Fortschr Med; 1999 Oct 28; 141(43):29-32. PubMed ID: 10912118
    [Abstract] [Full Text] [Related]

  • 3. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study.
    Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Meisl T, Pinter G, Dieplinger H.
    Thromb Haemost; 1995 Oct 28; 74(4):1025-8. PubMed ID: 8560405
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of low molecular weight heparin on lipid parameters in hemodialysis patients.
    Elisaf MS, Bairaktari H, Germanos N, Pappas M, Koulouridis E, Papagalanis N, Siamopoulos KC.
    Int Angiol; 1996 Sep 28; 15(3):252-6. PubMed ID: 8971586
    [Abstract] [Full Text] [Related]

  • 5. Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis.
    Schmitt Y, Schneider H.
    Nephrol Dial Transplant; 1993 Sep 28; 8(5):438-42. PubMed ID: 8393549
    [Abstract] [Full Text] [Related]

  • 6. Effects of low molecular weight heparin on the frequencies of intradialytic arrhythmias in hemodialysis patients.
    Miyauchi H, Matsumoto Y, Futenma A, Amano I, Miyauchi J, Matsuo S.
    Ren Fail; 2006 Sep 28; 28(6):469-74. PubMed ID: 16928615
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 28; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H.
    Clin Nephrol; 1995 Apr 28; 43(4):268-77. PubMed ID: 7606882
    [Abstract] [Full Text] [Related]

  • 11. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease.
    Nassiri AA, Hakemi MS, Soulati M, Marashian M, Rahbar K, Azizi F.
    Iran J Kidney Dis; 2009 Jul 28; 3(3):162-7. PubMed ID: 19617666
    [Abstract] [Full Text] [Related]

  • 12. Long-term effect of low molecular weight heparin on serum lipids in hypertriglyceridemic chronic hemodialysis patients.
    Vlassopoulos D, Noussias C, Hadjipetrou A, Arvanitis D, Logothetis E, Magana P, Katopodis K, Hadjiconstantinou V.
    J Nephrol; 1997 Jul 28; 10(2):111-4. PubMed ID: 9238618
    [Abstract] [Full Text] [Related]

  • 13. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M, Graziani G, Tenconi PM, Martinelli I, Ponticelli C.
    Ann Ital Med Int; 1997 Jul 28; 12(2):67-71. PubMed ID: 9284597
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Jul 28; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipoperoxidation and hemodialysis.
    Ramos R, Martínez-Castelao A.
    Metabolism; 2008 Oct 28; 57(10):1369-74. PubMed ID: 18803940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.